NCT02116829

Brief Summary

The aim of this study is to examine the effects in humans of a moderate butter intake on risk markers of cardiovascular disease compared to a diet with the same amount of olive oil (refined and therefore without polyfenols). The primary parameters are total cholesterol, LDL- and HDL cholesterol and triglycerides. The secondary parameters are risk markers of diabetes type 2; plasma glucose and insuling as well as the inflammatory marker hs-CRP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 17, 2014

Completed
Last Updated

April 17, 2014

Status Verified

April 1, 2014

Enrollment Period

3 months

First QC Date

April 15, 2014

Last Update Submit

April 16, 2014

Conditions

Outcome Measures

Primary Outcomes (4)

  • Total cholesterol

    5 weeks

  • LDL cholesterol

    5 weeks

  • HDL cholesterol

    5 weeks

  • Triglycerides

    5 weeks

Secondary Outcomes (3)

  • Insulin

    5 weeks

  • Glucose

    5 weeks

  • hs-CRP

    5 weeks

Study Arms (2)

Danish butter, dairy

EXPERIMENTAL
Other: Danish butter

Olive oil, refined

ACTIVE COMPARATOR
Other: Olive oil

Interventions

The effect of butter intake versus olive oil (refined) intake on blood lipids (primarily)

Also known as: butter, diary
Danish butter, dairy
Olive oil, refined

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sign written consent
  • Age: 20-70 y
  • BMI: 18.5 - 32 kg/m2
  • Healthy men and women (with no known diseases)

You may not qualify if:

  • Current or previously cardiovascular disease, high blood pressure
  • Diabetes Mellitus or other severe chronic disease, including severe allergies
  • Use of dietary supplements and blood donations prior to, and during the study
  • Known or suspected abuse of alcohol, drugs or medication
  • Pregnant or are planning pregnancy during the study period
  • Extreme physical activity level (more than 10 hours tough physical activity pr. week)
  • Participation in other research studies
  • Inability, physically or mentally, to comply with the procedures required by the study protocol, as evaluated by the study staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition, Exercise and Sports

Copenhagen, Frederiksberg, 1958, Denmark

Location

Related Publications (1)

  • Engel S, Tholstrup T. Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet. Am J Clin Nutr. 2015 Aug;102(2):309-15. doi: 10.3945/ajcn.115.112227. Epub 2015 Jul 1.

MeSH Terms

Conditions

Atherosclerosis

Interventions

ButterOlive Oil

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Dietary FatsFatsLipidsDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesDietary Fats, UnsaturatedFats, UnsaturatedPlant OilsOils

Study Officials

  • Tine Tholstrup, PhD

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 15, 2014

First Posted

April 17, 2014

Study Start

September 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

April 17, 2014

Record last verified: 2014-04

Locations